DMAC

DMAC Change in Working Capital

$2.63MTTM · USD

Period ending:

DMAC FY Change in Working CapitalUSD
DMAC FY Change in Working Capital2004-12-31: $500.30K2005-12-31: -$655.16K2006-12-31: -$26.46K2007-12-31: $142.90K2008-12-31: $41.68K2009-12-31: -$35.59K2010-12-31: -$148.89K2011-12-31: $36.23K2012-12-31: $1.17M2013-12-31: $66.58K2014-12-31: $437.98K2015-12-31: -$52.97K2016-12-31: -$918.45K2017-12-31: -$44.00K2018-12-31: -$636.00K2019-12-31: $387.00K2020-12-31: $1.20M2021-12-31: -$461.00K2022-12-31: $585.00K2023-12-31: $93.00K2024-12-31: $1.51M2025-12-31: $675.00K$1.51M-$918.45K
2004-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DMAC change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 22 observations from Dec 31, 2004 to Dec 31, 2025.

Diamedica Therapeutics Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
675,000
1,512,000
93,000
585,000
-461,000
1,195,000
387,000
-636,000
-44,000
-918,450
-52,973
437,983
66,579
1,169,806
36,225
-148,894
-35,586
41,675
142,895
-26,460
-655,158
500,301

Compare change in working capital

All DMAC financial metrics · DMAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.